期刊
CLINICAL LUNG CANCER
卷 22, 期 4, 页码 E528-E532出版社
CIG MEDIA GROUP, LP
DOI: 10.1016/j.cllc.2020.04.012
关键词
Alectinib hepatotoxicity; ALK; CNS efficacy of brigatinib; CNS relapse; Dose-escalated brigatinib